PHOE vs SHMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PHOE exhibits a stable financial health profile with a Piotroski F-Score of 5/9 and a debt-free balance sheet, but it is fundamentally decoupled from its valuation. The stock trades at an astronomical P/E of 586.67 and a Price/Book of 50.72, while the Graham Number ($0.48) and Intrinsic Value ($0.21) suggest the current price of $17.60 is an extreme speculative premium. With revenue declining by 7.3% and earnings crashing by 76.1% YoY, there is no fundamental growth driver to justify the current market price.
SHMD exhibits a dangerous divergence between its skyrocketing stock price and deteriorating fundamentals. While the Piotroski F-Score of 4/9 suggests a 'stable' health baseline, this is contradicted by a negative Price/Book ratio of -4.20, indicating negative shareholder equity and severe balance sheet distress. With revenue crashing by 37.5% YoY and a current ratio of 0.60, the company faces significant liquidity risks. The recent price surge appears speculative and is unsupported by any intrinsic value or growth metrics.
Compare Another Pair
Related Comparisons
PHOE vs SHMD: Head-to-Head Comparison
This page compares Phoenix Asia Holdings Limited (PHOE) and SCHMID Group N.V. (SHMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.